An observational study in Cerebral Palsy, sponsored by MarsiBionics. Active, not recruiting at 5 sites in Spain. Open to participants aged 3 Years to 14 Years. Per ClinicalTrials.gov, last updated 2024-09-27.
Sponsored by MarsiBionics · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Cerebral Palsy with a site in Spain — 14 open to participants now, 17 under way, 1 of them phase 3. Cerebral Palsy · Spain.
Among the 54 studies in Cerebral Palsy with a site in Spain, this one is the 4th largest by planned enrollment of the 10 observational ones that give a count, is one of 10 that started in 2023, is one of 10 observational ones, reaches primary completion later than 6 of the 16 other live ones, and was the 31st registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →14 of the 54 studies in Cerebral Palsy with a site in Spain are open now. Recruiting first, the newest first:
Facultat de ciencies de la Salut Universitat Ramon Llull · Sites in Spain
Ages 18–80
University of Valencia · Sites in Spain
Ages 10–18
Fundación para la investigación biomética Hospital Infantil Universitario Niño Jesús · Sites in Spain
Ages 3–8
Universidade da Coruña · Sites in Spain
Ages 3–8
Universidad de Almeria · Sites in Spain
Ages 2–11 · Healthy volunteers
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 3 Years to 14 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 6
First in 2011; this study’s year is marked. 10 started in 2023.
This study's planned enrollment of 60 is close to the median of 63 across 474 observational studies indexed under Cerebral Palsy.
Median enrollment 32 across the 44 interventional studies, 50 across the 10 observational. Of the 33 that completed or were terminated, 4 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 54 have an industry lead sponsor. The 10 most frequent:
MarsiBionics is the lead sponsor of 14 studies on the registry; 3 are open to participants now.
MarsiBionics has 8 studies filed under Cerebral Palsy — fewer than ten, so there is no comparison to draw.
2 of the studies in Cerebral Palsy with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06438666University of MalagaEffects Obtained at Manual Function After Applying Anodic Transcranial Direct Current Stimulation (tCDS) in Children With Spastic Hemiparetic Cerebral Palsy | 2026-12-23 |
| NCT07745712ABLE Human Motion S.L.Clinical Investigation to Validate the Safety and Performance of the ABLE Kids Device in Pediatric Patients With Neurological Gait Disorders in a Clinical Setting | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 54 studies in Cerebral Palsy with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Cerebral Palsy (CP) is the first cause of motor disability in children worldwide. ATLAS 2030 is a robotic gait exoskeleton designed to rehabilitate children with motor disability. The objective of this study is to analyse the efficacy of a training program with ATLAS 2023 in chilren with CP.
A sample of children with CP will be divided into 2 groups, the experimental group will receive 32 sesions withe the ATLAS 2030 exoskeleton, whereas the control group will continue to receive their regular conventional therapy. Assessments will be performed at the beginning and the end of the intervention, as well as after 6, 9 and 12 months of the end of the intervention for follow-up.
Children diagnosed with cerebral palsy with Gross Motor Function Classification level III (children walk using a hand-held mobility device in most indoor settings) or IV (children use methods of mobility that require physical assistance or powered mobility in most settings).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
sessions of rehabilitation with the ATLAS 2030 exoskeleton twice per week as part of their of their routine rehabilitation
Device: ATLAS 2030
The children included in the control group will continue receiving their usual conventional therapy
sessions of rehabilitation with the ATLAS 2030 exoskeleton twice per week as part of their routine rehabilitation
Gross Motor Function Measure-88 (GMFM-88)
To measure changes in gross motor function in children with cerebral palsy using the Gross Motor Functional Measure-88. The minimum value is 0 and the maximum value is 100 .When the GMFM score is lower, the skill level is lower.
Time frame: At the beginning and the end of the intervention (4 months), as well as after 6, 9 and 12 months (follow-up)
Modified Ashworth Scale (MAS)
changes in spasticity measured by the Modified Ashworth Scale (MAS). The spasticity of each muscle group is measured with a scale scored from 0 to 4, where 0 means no spasticity and 4 means the joint is fixed and therefore, the highest level of spasticity
Time frame: Through study completion, along 1 year
Pediatric Quality of Life Inventory (PedsQLTM)
Changes in self perceived quality of life measured by the Pediatric Quality of Life Inventory (PedsQLTM). Every item is measured on a scale from 0 (higher quality of life) to 4 (lower quality of life)
Time frame: At the beginning and the end of the intervention (4 months), as well as after 6, 9 and 12 months (follow-up)
Changes in Gait Deviation Index (GDI)
Changes in Gait Deviation Index (GDI) measured with a tridimensional motion analysis system
Time frame: At the beginning and the end of the intervention (4 months), as well as after 6, 9 and 12 months (follow-up)
Plan to share: No
No publications or documents are linked to this record.
Started Aug 2023 (actual). Primary completion is estimated for May 2025, 21 months after the start.
Of 221 observational studies under Cerebral Palsy, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 60. This study's planned 21 months is close to that.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
MarsiBionics